Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
373
-
Total 13F shares, excl. options
-
56.2M
-
Shares change
-
+2.48M
-
Total reported value, excl. options
-
$9.67B
-
Value change
-
+$436M
-
Put/Call ratio
-
0.42
-
Number of buys
-
209
-
Number of sells
-
-135
-
Price
-
$172.30
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2018
430 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q2 2018.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 373 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.2M shares
.
Largest 10 shareholders include FMR LLC (6.63M shares), PUTNAM INVESTMENTS LLC (4.91M shares), VANGUARD GROUP INC (4.86M shares), BlackRock Inc. (4.37M shares), JPMORGAN CHASE & CO (1.81M shares), Bank of New York Mellon Corp (1.48M shares), TIAA CREF INVESTMENT MANAGEMENT LLC (1.32M shares), Partner Fund Management, L.P. (1.24M shares), STATE STREET CORP (1.21M shares), and Boston Partners (1.09M shares).
This table shows the top 373 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.